Explaining the Paucity of Intratumoral T Cells: A Construction Out of Known Entities

被引:5
|
作者
Fearon, Douglas T. [1 ,2 ,3 ]
机构
[1] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA
[2] Weill Cornell Med, New York, NY 10065 USA
[3] Univ Cambridge, Cambridge CB2 1TN, England
来源
关键词
CHEMOKINE RECEPTOR; PD-1; BLOCKADE; ANTI-PD-L1; ANTIBODY; ANTITUMOR IMMUNITY; PROGNOSTIC-FACTOR; FACTOR-I; CXCR4; CXCL12; EXPRESSION; NIVOLUMAB;
D O I
10.1101/sqb.2016.81.030783
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This essay addresses the question of how tumors escape control by the immune system. The literature strongly points to inadequate accumulation of T cells among cancer cells as being the proximate cause, but this observation has no acceptable explanation as yet. An approach to this problem is adopted wherein the chemokines and chemokine receptors that normally mediate the trafficking of T cells to inflamed tissues are reviewed and considered in the context of their relative levels of expression in a transplanted colorectal tumor model. This method of reasoning-consistent with Bertrand Russell's (1985) advice, "Whenever possible, substitute constructions out of known entities for inferences to unknown entities"-leads to the proposal that signaling via the chemokine receptor, CXCR4, impairs the function of CXCR3 on the immune cells that are responsible for suppressing the growth of cancers.
引用
收藏
页码:219 / 226
页数:8
相关论文
共 50 条
  • [1] An atlas of intratumoral T cells
    van der Leun, Anne M.
    Schumacher, Ton N.
    [J]. SCIENCE, 2021, 374 (6574) : 1446 - 1447
  • [2] Role of VEGF in the depletion of T cells intratumoral
    Voron, Thibault
    Tartour, Eric
    Taieb, Julien
    Terme, Magali
    [J]. M S-MEDECINE SCIENCES, 2015, 31 (05): : 473 - 475
  • [3] Explaining Resistance to CAR T Cells
    Leslie, Mitch
    [J]. CANCER DISCOVERY, 2018, 8 (07) : 784 - 785
  • [4] Regulation of T cells by mTOR: the known knowns and the known unknowns
    Pollizzi, Kristen N.
    Powell, Jonathan D.
    [J]. TRENDS IN IMMUNOLOGY, 2015, 36 (01) : 13 - 20
  • [5] Intratumoral T cells in recurrent epithelial ovarian carcinomas
    Kim, S. H.
    Lee, K. K.
    Adams, S.
    Cadungog, M.
    Chu, C. S.
    Katsaros, D.
    Gimotty, P.
    Coukos, G.
    [J]. GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S38 - S38
  • [6] Not Sweet: Glucocorticoids from Intratumoral Myeloid Cells Disable T Cells
    Effern, Maike
    Hoelzel, Michael
    [J]. IMMUNITY, 2020, 53 (03) : 476 - 478
  • [7] Paucity of natural killer and cytotoxic T cells in human neuromyelitis optica lesions
    Saadoun, Samira
    Bridges, Leslie R.
    Verkman, A. S.
    Papadopoulos, Marios C.
    [J]. NEUROREPORT, 2012, 23 (18) : 1044 - 1047
  • [8] Explaining variance; Or, stuck in a moment we can't get out of
    Braumoeller, Bear F.
    [J]. POLITICAL ANALYSIS, 2006, 14 (03) : 268 - 290
  • [9] γδ T cells reach out
    Elisabeth Kugelberg
    [J]. Nature Reviews Immunology, 2015, 15 (7) : 403 - 403
  • [10] Immunophenotyping of Circulating and Intratumoral Myeloid and T Cells in Glioblastoma Patients
    Marx, Sascha
    Wilken, Fabian
    Miebach, Lea
    Ispirjan, Mikael
    Kinnen, Frederik
    Paul, Sebastian
    Bien-Moeller, Sandra
    Freund, Eric
    Baldauf, Jorg
    Fleck, Steffen
    Siebert, Nikolai
    Lode, Holger
    Stahl, Andreas
    Rauch, Bernhard H.
    Singer, Stephan
    Ritter, Christoph
    Schroeder, Henry W. S.
    Bekeschus, Sander
    [J]. CANCERS, 2022, 14 (23)